Fig. 3From: Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort studyKaplan Meier survival curves of overall survival (metastatic organs ≥ 2; metastatic organs < 2)Back to article page